Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice
2016
Parenteral Anticoagulants
2008
Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism
2009
A systems approach to prion disease
2009
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
Designing materials for biology and medicine
2004 StandoutNature
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
2013 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Contribution of platelets to tumour metastasis
2011 Standout
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
2016
Antithrombotic Therapy for VTE Disease
2016 Standout
Binding a heparin derived disaccharide to defensin inspired peptides: insights to antimicrobial inhibition from gas-phase measurements
2010 StandoutNobel
Network medicine: a network-based approach to human disease
2010 Standout
StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism
2003
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis
2003
Androgen synthesis in adrenarche
2008
Antithrombotic Therapy for VTE Disease
2012 Standout
Differential Gene Regulation of StarD4 and StarD5 Cholesterol Transfer Proteins
2005
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
1993
Heparin and Low-Molecular-Weight Heparin
2004
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Lysine-Heparin Interactions in Antithrombin. Properties of K125M and K290M,K294M,K297M Variants
1994
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Metabolic control through the PGC-1 family of transcription coactivators
2005 Standout
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis
2014
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Prevention and Treatment of Thromboembolic and Ischemic Complications Associated with Endovascular Procedures: Part I???Pathophysiological and Pharmacological Features
2000
Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter
2007
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Bile acids as regulatory molecules
2009
Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice
2016
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine
1995
Synthetic extracellular matrices for in situ tissue engineering
2004
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Discovery of the cellular and molecular basis of cholesterol control
2013 StandoutNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Christian Raetz: Scientist and Friend Extraordinaire
2013 StandoutNobel
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Influence of Sulfation on Platelet Aggregation and Activation with Differentially Sulfated Hyaluronic Acids
1998
Localization and characterization of a heparin binding domain peptide of human von Willebrand factor.
1992
Anticoagulation Monitoring during Cardiac Surgery
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Characterization and Mutagenesis of Gal/GlcNAc-6-O-sulfotransferases
2002 StandoutNobel
Carbohydrate Sulfotransferases of the GalNAc/Gal/GlcNAc6ST Family
2002 StandoutNobel
Low molecular weight heparin
1992
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins
1993
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Analysis of the Structure and Function of the von Willebrand Factor A1 Domain Using Targeted Deletions and Alanine-Scanning Mutagenesis
1996
Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin
1994
Ultralarge von Willebrand Factor Fibers Mediate Luminal Staphylococcus aureus Adhesion to an Intact Endothelial Cell Layer Under Shear Stress
2013
Starvation response in mouse liver shows strong correlation with life-span-prolonging processes
2004
MXL-3 and HLH-30 transcriptionally link lipolysis and autophagy to nutrient availability
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
A Stereochemical Surprise at the Late Stage of the Synthesis of Fully N-Differentiated Heparin Oligosaccharides Containing Amino, Acetamido, and N-Sulfonate Groups
2004
Comparison of Unfractionated Versus Low Molecular Weight Heparin for Deep Vein Thrombosis Prophylaxis During Breast and Pelvic Cancer Surgery: Efficacy, Safety, and Follow-up
1998
Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis
2002
Biologically Engineered Protein-graft-Poly(ethylene glycol) Hydrogels: A Cell Adhesive and Plasmin-Degradable Biosynthetic Material for Tissue Repair
2002
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Adhesion Mechanisms in Platelet Function
2007
STARD4 abundance regulates sterol transport and sensing
2011
Low molecular weight heparin
1992
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Dalila Marques being referenced
Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis
2004
Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation
2008
Transport of Cholesterol into Mitochondria Is Rate-limiting for Bile Acid Synthesis via the Alternative Pathway in Primary Rat Hepatocytes
2002
Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells
2005
Heparin binding domain peptides of antithrombin III: Analysis by isothermal titration calorimetry and circular dichroism spectroscopy
1994
Regulation of oxysterol 7α-hydroxylase (CYP7B1) in the rat
2003
Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families – 15 new mutations
2011
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
1991
Overexpression of cholesterol transporter StAR increases In Vivo rates of bile acid synthesis in the rat and mouse
2004
Structural Aspects of Heparin Responsible for Interactions With von Willebrand Factor
1997
Synthesis and biological activity of a model disaccharide containing a key unit in heparin for binding to platelets
1996